1,145.11 USD
↘ 4.74 (0.41%)LIVE (AS OF 02:35 PM EDT)
Shares of Eli Lilly & Co. (LLY) are trading at $1,145.11. Our models show a "Neutral" technical signal alongside a "Buy" fundamental rating. This is driven by a robust Altman Z-Score, exceptional Return on Equity (78.8%) and a bullish Golden Cross on the moving averages. On the valuation front, LLY trades at elevated multiples relative to its peers, earning a "Richly Valued" assessment.
Technical & fundamental data as of Oct 1, 2026.
Open?$1,153.82
High?$1,164.17
Low?$1,136.98
Prev. Close?$1,149.85
Volume?1.0M
Avg. Volume?2.4M
VWAP?$1,147.53
Rel. Volume?0.43x
Bid / Ask
Bid?$1,142.92 × 40
Ask?$1,143.91 × 40
Spread?$0.99
Midpoint?$1,143.42
Valuation & Ratios
Market Cap?1024.9B
Shares Out?941.4M
Float?849.7M
Float %?90.3%
P/E Ratio?38.37
P/B Ratio?30.25
EPS?$29.97
Dividend?0.56%
Ex-Dividend?N/A
News
Profile
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio and Jaypirca for cancer; Mounjaro, Zepbound, Foundayo, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
Themes
Employees
50.0K
Market Cap
1024.9B
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
1970-07-09
Address
LILLY CORPORATE CTR
INDIANAPOLIS, IN 46285
Phone: (317) 276-2000
INDIANAPOLIS, IN 46285
Phone: (317) 276-2000
Technical OutlookNeutral
Strong SellNeutralStrong Buy
Long-Term (Tide)?– Neutral(0/3)
Medium-Term (Wave)?▲ Bullish(+1/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookBuy
Strong SellNeutralStrong Buy
F-Score?77
Z-Score?100
Momentum?60
Short Sent.?57
Piotroski F-Score?6/9Mixed
Altman Z-Score?7.47Safe
Confidence?72%Moderate
Short InterestModerate
Short % of Float?0.89%Low
Short Interest?7.5M
Days to Cover?3.4
Free Float849.7M
Avg Daily Volume2.2M
Settlement Date2026-09-15
Financial Health
Current Ratio?1.35Adequate
Quick Ratio?1.00Adequate
Cash Ratio?0.19Low
Debt/Equity?1.62High
ValuationRICHLY VALUEDvs 10 peers + S&P 500
Score33/100
P/E?38.4PRICEY▾
Peers40
S&P19
P/B?30.25HIGH▾
Peers10
S&P3
P/S?12.87HIGH▾
Peers20
S&P3
P/FCF?56.4PRICEY▾
Peers10
S&P8
EV/EBITDA?25.7HIGH▾
Peers30
S&P15
EV/Sales?13.44HIGH▾
Peers20
S&P5
Returns & Efficiency
ROE?78.8%STRONG▾
Peers89
S&P97
ROA?18.8%STRONG▾
Peers80
S&P93
Cash Flow & Enterprise
FCF?$18.2B
Enterprise Value?$1070.9B
Fundamentals ratios updated end of day